Skip to main content

Table 1 Demographic and clinical variables in the study sample as compared to the Phelan-McDermid Syndrome International Registry (PMSIR) participants 13 or older

From: Psychiatric illness and regression in individuals with Phelan-McDermid syndrome

 

This study (n = 38)

PMSIR (n = 130)

Comparison

Mean age at data collection

24.7 years ± 9.92

20.8 years ± 7.65

t(166) = 2.56, p = .011

χ2(1) = 10.21, p = .001

Gender

 Male

18% (7/38)

47% (61/130)

χ2(1) = 10.20, p = .001

 Female

82% (31/38)

53% (69/130)

Genetic defect a

 Terminal deletion

61% (23/38)

91% (118/130)

χ2(1) = 19.79, p < .001

 Interstitial deletion

2% (3/130)

SHANK3 sequence variant

39% (15/38)

7% (9/130)

ASD diagnosis (ever)d

55% (21/38)

41% (37/91b)

χ2(1) = 2.105, p = .147

History afebrile seizure(s)

39% (15/38)

41% (37/91)

χ2(1) = .044, p = .834

Walked independently (ever)

100% (38/38)

81% (64/79c)

χ2(1) = 8.212, p = .004

Spoke in phrases or sentences (ever)

79% (30/38)

51% (40/79)

χ2(1) = 8.317, p = .004

Toileted independently “always” or “sometimes” (ever)

89% (34/38)

48% (38/79)

χ2(1) = 18.029, p < .001

Dressed self independently (ever)

78% (30/38)

42% (33/79)

χ2(1) = 13.26, p < .001

Chronic constipation

84% (32/38)

15% (14/91)

χ2(1) = 55.428, p = <.001

Acute urinary retention

47% (18/38)

3% (3/87)

χ2(1) = 37.091, p < .001

  1. aAmong all Registry participants (n = 509, excluding the study participants), there are 467 terminal deletions (92%), 10 interstitial deletions (2%) and 32 sequence variants (6%)
  2. b91 participants in this age range (excluding the study participants) completed the Registry Clinical Questionnaire
  3. c79 participants in this age range (excluding the study participants) completed the Registry Developmental Questionnaire
  4. dPrior to the onset of neuropsychiatric illness, 42% (16/38) of participants had ASD diagnoses